EC
WVE icon

EcoR1 Capital’s Wave Life Sciences WVE Stock Holding History

EcoR1 Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-233,933
Closed -$9.84M – 54
2018
Q4 		$9.84M Buy
233,933
+189,092
+422% +$8.41M 0.98% 31
2018
Q3 		$2.24M Sell
44,841
-368,030
-89% -$16.6M 0.2% 43
2018
Q2 		$15.8M Sell
412,871
-1,046,201
-72% -$45M 1.5% 20
2018
Q1 		$58.5M Buy
1,459,072
+522,909
+56% +$22M 5.87% 6
2017
Q4 		$32.9M Buy
936,163
+371,915
+66% +$10.8M 3.7% 9
2017
Q3 		$12.3M Buy
+564,248
New +$11.3M 1.64% 17
2017
Q2 		– Sell
-10,000
Closed -$275K – 39
2017
Q1 		$275K Buy
+10,000
New +$279K 0.07% 32

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

EcoR1 Capital's WVE Position: Q1 2019 in Review

EcoR1 Capital sold out of Wave Life Sciences (WVE) in Q1 2019, closing a stake of 233,933 shares — an estimated $9.84M sold.

EcoR1 Capital first reported a position in WVE in Q1 2017 and held it in 7 quarters. The position peaked at $58.5M in Q1 2018. 110 funds tracked by Wall St. Rank hold WVE as of Q1 2019.

  • EcoR1 Capital reported no remaining Wave Life Sciences position as of Q1 2019 after selling out during the quarter.
  • EcoR1 Capital sold 233,933 Wave Life Sciences shares in Q1 2019, an estimated $9.84M.
  • EcoR1 Capital first reported a position in Wave Life Sciences in Q1 2017 and held it in 7 quarters.
  • EcoR1 Capital's Wave Life Sciences position peaked at $58.5M in Q1 2018.
  • 110 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2019.

Based on EcoR1 Capital's 13F filing for Q1 2019, filed 15 May 2019.